AMERICAN INTERNATIONAL GROUP, INC. - ALLOGENE THERAPEUTICS INC ownership

ALLOGENE THERAPEUTICS INC's ticker is ALLO and the CUSIP is 019770106. A total of 154 filers reported holding ALLOGENE THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 7.07 and the average weighting 0.1%.

Quarter-by-quarter ownership
AMERICAN INTERNATIONAL GROUP, INC. ownership history of ALLOGENE THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$130,008
-33.9%
41,012
+3.7%
0.00%0.0%
Q2 2023$196,578
+3.5%
39,553
+2.8%
0.00%0.0%
Q1 2023$190,007
-19.9%
38,463
+2.0%
0.00%
-50.0%
Q4 2022$237,120
-42.0%
37,698
-0.4%
0.00%
-33.3%
Q3 2022$409,000
-3.8%
37,835
+1.4%
0.00%0.0%
Q2 2022$425,000
+38.0%
37,301
+10.5%
0.00%
+50.0%
Q1 2022$308,000
-42.9%
33,761
-6.6%
0.00%
-33.3%
Q4 2021$539,000
-43.7%
36,137
-2.9%
0.00%
-40.0%
Q3 2021$957,000
-3.7%
37,218
-2.3%
0.01%
+66.7%
Q2 2021$994,000
-10.4%
38,103
+21.3%
0.00%
-25.0%
Q1 2021$1,109,000
+40.2%
31,423
+0.3%
0.00%
+33.3%
Q4 2020$791,000
-35.0%
31,340
-2.8%
0.00%
-50.0%
Q3 2020$1,216,000
-4.3%
32,240
+8.7%
0.01%0.0%
Q2 2020$1,270,000
+184.8%
29,668
+29.2%
0.01%
+200.0%
Q1 2020$446,000
-29.3%
22,962
-5.5%
0.00%0.0%
Q4 2019$631,000
-5.5%
24,288
-0.8%
0.00%
-33.3%
Q3 2019$668,000
+0.9%
24,493
-0.7%
0.00%0.0%
Q2 2019$662,000
+63.1%
24,664
+75.6%
0.00%
+50.0%
Q1 2019$406,000
+7.1%
14,047
-0.2%
0.00%0.0%
Q4 2018$379,00014,0780.00%
Other shareholders
ALLOGENE THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Vida Ventures Advisors, LLC 1,798,163$5,700,1778.82%
Wildcat Capital Management, LLC 1,920,787$6,088,8952.44%
TPG GP A, LLC 18,716,306$59,330,6901.02%
EcoR1 Capital, LLC 4,488,200$14,227,5940.48%
CROSSPOINT FINANCIAL, LLC 12,000$38,0400.40%
Coastal Bridge Advisors, LLC 406,847$1,289,7050.35%
CAXTON ASSOCIATES LP 480,104$1,521,9300.21%
Woodline Partners LP 5,313,915$16,845,1110.20%
Rhenman & Partners Asset Management AB 300,000$951,0000.10%
Navalign, LLC 75,365$238,9070.09%
View complete list of ALLOGENE THERAPEUTICS INC shareholders